Completed
A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma
NCT01703312
- Conditions
- Allergic Asthma, Asthma, Bronchial Diseases, +8 more
- Locations
-
- Novartis Investigative Site Calgary, Alberta, Canada
- Novartis Investigative Site Edmonton, Alberta, Canada
- Novartis Investigative Site Hamilton, Ontario, Canada
- Novartis Investigative Site Ste-Foy, Quebec, Canada